The latest from the BIO 2025 conference: more universities open to private equity deals, emerging companies turn to new ...

Nicole Verdun, director of the office that reviews cell and gene therapies at the Food and Drug Administration, and her ...

A new twice-yearly shot could be a "game changer" in the fight against AIDS, but experts' hopes have dimmed because of the ...

Gilead has won FDA approval for an HIV prevention shot that is administered only once every six months. When will low-income ...

Vinay Prasad is taking on several big roles at the FDA, solidifying his position as a top adviser to Commissioner Marty ...

Tennessee’s ban on gender-affirming care for minors can stand after the Supreme Court ruled that it does not constitute ...

Native American deaths are significantly undercounted because of errors in death certificates, a new study claims.

HHS secretary Robert F. Kennedy Jr. declared that the FDA’s “suppression of psychedelics” was about to end. Now he and his ...

“Using a common-sense approach, the national priority review program will allow companies to submit the lion’s share of the ...

Duchenne muscular dystrophy families are sharing stories about Elevidys complications on social media. But they aren’t ...

This is the web edition of STAT’s AI Prognosis newsletter, our subscriber-exclusive guide to AI in health care and medicine.

Scholar Rock said its investigational therapy helped preserve lean mass among patients taking a powerful weight loss drug.